Health Populi
MAY 24, 2018
2017 was a banner year of innovative drug launches in oncology, Aitken coined, with more drugs used more extensively, driving improved patient for people dealing with cancer. In the US, spending on oncology doubled from 2012 to 2017, to $50 bn. All oncology products launched in 2017 had list prices above $100,000 per year in the U.S.;
Health Populi
APRIL 23, 2018
in 2017 after accounting for discounts and rebates. a report from the IQVIA Institute for Health Data Science. a report from the IQVIA Institute for Health Data Science. The report reviews medicines spending in 2017 looking forward to 2022. billion prescriptions dispensed in 2017, and generic drugs accounted 90% of them.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Health Populi
OCTOBER 12, 2018
I wrote this post on the deal as an inflection point in American healthcare on 3rd December 2017 when CVS and Aetna announced their marriage intentions. This post updates my initial thoughts on the deal, given the morphing US healthcare market on both the traditional health services front and fast-evolving retail health environment.
Health Populi
MAY 8, 2019
Two-thirds of Rx’s were dispensed to treat chronic conditions, notably hypertension, mental health, lipid management, diabetes, and anti-coagulants. In 2017, nearly 60% of new therapy starts were for the Flucelvax Quadrivalent flu vaccine. increase over 2017 net of rebates, discounts, and price concessions.
Insulin Nation
APRIL 9, 2018
This piece, written by Emily Kopp, Sydney Lupkin, and Elizabeth Lucas, originally appeared on Kaiser Health News , which authorized the republication. The first-of-its-kind database, compiled by Kaiser Health News, tallies the money from Big Pharma to patient groups. The database identifies over 1,200 patient groups.
Health Populi
JULY 1, 2019
And PLM did business deals with large pharmaceutical companies who wanted the data to advance their research and development efforts – that’s how the PLM business was primarily funded. Patients knew this – PLM was emphatic about transparency in its community and the company never hid what they were doing with people’s data.
ACA Times
FEBRUARY 1, 2016
A bill in New Mexico would create a task force on pharmaceutical pricing, while a proposed law in Washington State would cap consumers’ out-of-pocket spending on prescription medications. Geoffrey Joyce , director of the Schaeffer Center for Health Policy & Economics at the University of Southern California.
Expert insights. Personalized for you.
204 
Let's personalize your content